上气道刺激对中重度阻塞性睡眠呼吸暂停老年患者的疗效反应
ADHERE多中心观察性研究纳入2016年10月至2018年4月接受上气道刺激植入的患者,按年龄<65岁与≥65岁分组。两组12个月AHI均较基线下降(P<.001),但老年组下降幅度更大(7.6±6.9 vs 11.9±13.4,P=.01),使用时长略高(6.0±2.0 vs 5.4±2.1小时/晚,P=.02),手术时间与并发症均低。
要点
- 年龄≥65岁与<65岁患者12个月AHI均较基线下降,P<.001。
- 老年组AHI下降幅度大于年轻组(7.6±6.9 vs 11.9±13.4,P=.01)。
- 老年组使用时长略高于年轻组(6.0±2.0 vs 5.4±2.1小时/晚,P=.02)。
核心结论
- 接受上气道刺激治疗的年龄≥65岁患者,其AHI下降和治疗使用时长略高于年轻患者,手术并发症低,与传统睡眠手术形成对比。
研究设计与样本
- 多中心观察性研究,ADHERE注册数据库纳入2016年10月至2018年4月接受上气道刺激植入的患者。
- 数据按年龄分为<65岁组(n=365)与≥65岁组(n=235)。
- 研究场所为13家美国医院和3家德国医院。
主要发现
- 年轻组平均年龄52.7±7.9岁,男性82%,体重指数29.6±3.8;老年组平均年龄71.1±4.8岁,男性71%,体重指数28.8±3.8。
- 基线AHI两组相似(年轻组36.2±15.9 vs 老年组36.1±14.8)。
- 12个月时两组AHI均较基线下降(P<.001),老年组下降幅度更大(7.6±6.9 vs 11.9±13.4,P=.01)。
- Epworth嗜睡量表评分年轻组从12.3±5.4降至7.1±4.8(P<.001),老年组从10.7±5.7降至6.3±4.4(P<.001)。
- 使用时长老年组略高于年轻组(6.0±2.0 vs 5.4±2.1小时/晚,P=.02);手术时间年轻组2.4±0.7小时 vs 老年组2.3±0.7小时(P=.40),并发症均低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of age on safety, efficacy, and usage of upper airway stimulation (UAS). STUDY DESIGN: Multicenter observational study. SETTING: Thirteen US hospitals and 3 German hospitals. SUBJECTS AND METHODS: The ADHERE registry is a multicenter database enrolling patients undergoing UAS implantation from October 2016 to April 2018. Outcome measures included the Epworth Sleepiness Scale, apnea-hypopnea index (AHI), therapy usage, and complications. Data were segmented by age (<65 vs ≥65 years). RESULTS: Younger adults (n = 365) were a mean ± SD 52.7 ± 7.9 years old and 82% male, with a body mass index of 29.6 ± 3.8. Older adults (n = 235) were 71.1 ± 4.8 years old and 71% male, with a body mass index of 28.8 ± 3.8. Baseline AHI was similar (younger, 36.2 ± 15.9; older, 36.1 ± 14.8). Both groups had lower AHI at 12 months versus baseline (P < .001), but the older group showed a greater reduction (7.6 ± 6.9 vs 11.9 ± 13.4, P = .01). The Epworth Sleepiness Scale score decreased from 12.3 ± 5.4 to 7.1 ± 4.8 (P < .001) among younger adults and from 10.7 ± 5.7 to 6.3 ± 4.4 (P < .001) among older adults. Usage was slightly higher among older adults (6.0 ± 2.0 vs 5.4 ± 2.1 hours/night, P = .02). Surgical time was similar between younger patients (2.4 ± 0.7 hours) and older patients (2.3 ± 0.7 hours, P = .40), with comparably low complications. CONCLUSION: AHI reduction and therapy usage were found to be somewhat higher among patients aged ≥65 years who were treated with UAS. Surgical complications were low, in contrast to traditional sleep surgery.
引用
- Withrow K, Evans S, Harwick J, et al. Upper Airway Stimulation Response in Older Adults with Moderate to Severe Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2019. PMID: 31084350. doi:10.1177/0194599819848709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。